Intracoronary versus Intravenous Administration of Abciximab in Patients with Acute Coronary Syndrome: A Meta-Analysis

• Jie-Ning Wang ,

  Contributed equally to this work with: Jie-Ning Wang, Shu Diao, Yuan-Jun Tang

  Affiliation Director of the Hospital, Shanghai Seventh People’s Hospital, Shanghai, China

  ⨯
• Shu Diao ,

  Contributed equally to this work with: Jie-Ning Wang, Shu Diao, Yuan-Jun Tang

  Affiliation Vice Director of the Hospital, Shanghai Seventh People’s Hospital, Shanghai, China

  ⨯
• Yuan-Jun Tang ,

  Contributed equally to this work with: Jie-Ning Wang, Shu Diao, Yuan-Jun Tang

  Affiliation Department of Pharmaceutical Analysis, School of Pharmacy, Second Military Medical University, Shanghai, China

  ⨯
• An-Ji Hou,

  Affiliation Department of Oncology, Shanghai Seventh People’s Hospital, Shanghai, China

  ⨯
• Hai-Bo Yuan,

  Affiliation Department of Science, Shanghai Seventh People’s Hospital, Shanghai, China

  ⨯
• Yan Zheng,

  Affiliation Department of Science, Shanghai Seventh People’s Hospital, Shanghai, China

  ⨯
• Yu-Hao Zhou

  * E-mail: zhou_ly@126.com

  Affiliation Department of Rehabilitation Institute, Shanghai Seventh People’s Hospital, Shanghai, China

  ⨯